- /
- Supported exchanges
- / US
- / OCS.NASDAQ
Oculis Holding AG Ordinary shares (OCS NASDAQ) stock market data APIs
Oculis Holding AG Ordinary shares Financial Data Overview
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Oculis Holding AG Ordinary shares (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Oculis Holding AG Ordinary shares data using free add-ons & libraries
Get Oculis Holding AG Ordinary shares Fundamental Data
Oculis Holding AG Ordinary shares Fundamental data includes:
- Net Revenue: 791 K
- EBITDA: -77 789 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: -0.4116
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Oculis Holding AG Ordinary shares News
New
J.P. Morgan Bangs the Drum on These 2 ‘Strong Buy’ Stocks
We’ve turned the calendar on 2026, and the market’s focus is on what comes next. The big questions haven’t changed: can the bull run extend into the new year? Is AI showing signs of a bubble, or...
S&P 500 and Dow Rally to Record Highs as Tech Stocks Surge
The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.62%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.99%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.94%. March E-mini ...
S&P 500 and Dow Rally to Record Highs as Tech Stocks Surge
The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.62%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.99%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.94%. March E-mini ...
Stocks Supported by AI Investment and Strength in Miners
The S&P 500 Index ($SPX) (SPY) today is up +0.26%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.49%. March E-mini S&P futures (ESH2...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.